VEGFA and colorectal cancer: To examine HLX10’s ability to synergize with anti -VEGF blockade, we evaluated in vivo activity of HLX10 in combination with Bevacizumab (HLX04, Avastin biosimilar) in the human colorectal cancer cell line HT-29/hPBMC xenograft model.